Janus Henderson Group PLC Bio Rad Laboratories, Inc. Transaction History

Janus Henderson Group PLC

  • $187 Billion
  • Q3 2024

A detailed history of Janus Henderson Group PLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 1,204 shares of BIO stock, worth $437,292. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,204
Previous 2,647 54.51%
Holding current value
$437,292
Previous $722,000 44.32%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$263.97 - $344.64 $380,908 - $497,315
-1,443 Reduced 54.51%
1,204 $402,000
Q2 2024

Aug 14, 2024
SELL
$268.26 - $339.48 $29,240 - $37,003
-109 Reduced 3.96%
2,647 $722,000
Q1 2024

May 15, 2024
BUY
$304.11 - $351.99 $912 - $1,055
3 Added 0.11%
2,756 $953,000
Q4 2023

Feb 14, 2024
SELL
$269.37 - $365.04 $4,309 - $5,840
-16 Reduced 0.58%
2,753 $888,000
Q3 2023

Nov 14, 2023
SELL
$350.25 - $422.63 $50,085 - $60,436
-143 Reduced 4.91%
2,769 $992,000
Q2 2023

Aug 14, 2023
SELL
$359.49 - $486.4 $91,669 - $124,032
-255 Reduced 8.05%
2,912 $1.1 Million
Q1 2023

May 15, 2023
SELL
$418.69 - $503.0 $6.25 Million - $7.51 Million
-14,925 Reduced 82.5%
3,167 $1.52 Million
Q4 2022

Feb 14, 2023
BUY
$351.71 - $456.01 $1.73 Million - $2.24 Million
4,922 Added 37.37%
18,092 $7.61 Million
Q3 2022

Nov 14, 2022
BUY
$412.59 - $563.26 $428,268 - $584,663
1,038 Added 8.56%
13,170 $5.5 Million
Q2 2022

Aug 15, 2022
SELL
$463.67 - $597.16 $16.8 Million - $21.6 Million
-36,193 Reduced 74.89%
12,132 $6.01 Million
Q1 2022

May 16, 2022
SELL
$524.57 - $735.42 $11.2 Million - $15.7 Million
-21,323 Reduced 30.62%
48,325 $27.2 Million
Q4 2021

Feb 14, 2022
SELL
$708.84 - $794.68 $39.6 Million - $44.4 Million
-55,859 Reduced 44.51%
69,648 $52.6 Million
Q3 2021

Nov 16, 2021
SELL
$657.71 - $825.77 $16.4 Million - $20.6 Million
-24,950 Reduced 16.58%
125,507 $93.6 Million
Q2 2021

Aug 16, 2021
BUY
$576.64 - $649.04 $34 Million - $38.2 Million
58,933 Added 64.39%
150,457 $96.9 Million
Q1 2021

May 17, 2021
BUY
$547.01 - $662.35 $18.9 Million - $22.9 Million
34,635 Added 60.88%
91,524 $52.3 Million
Q4 2020

Feb 16, 2021
BUY
$510.68 - $643.45 $6.43 Million - $8.1 Million
12,587 Added 28.41%
56,889 $33.2 Million
Q3 2020

Nov 16, 2020
BUY
$454.43 - $535.6 $5.92 Million - $6.98 Million
13,023 Added 41.63%
44,302 $22.8 Million
Q2 2020

Aug 14, 2020
BUY
$334.87 - $493.06 $10.2 Million - $15.1 Million
30,599 Added 4499.85%
31,279 $14.1 Million
Q1 2020

May 14, 2020
BUY
$320.01 - $409.07 $217,606 - $278,167
680 New
680 $238,000
Q2 2019

Jul 31, 2019
SELL
$286.93 - $312.59 $248,481 - $270,702
-866 Closed
0 $0
Q1 2019

Apr 30, 2019
SELL
$224.3 - $317.41 $108,336 - $153,309
-483 Reduced 35.8%
866 $265,000
Q4 2018

Feb 06, 2019
BUY
$220.1 - $309.0 $296,914 - $416,841
1,349 New
1,349 $313,000
Q3 2018

Nov 09, 2018
SELL
$289.28 - $326.15 $925,695 - $1.04 Million
-3,200 Closed
0 $0
Q2 2018

Aug 10, 2018
SELL
$244.1 - $303.88 $3.44 Million - $4.29 Million
-14,110 Reduced 81.51%
3,200 $923,000
Q1 2018

May 14, 2018
SELL
$233.97 - $274.11 $2.95 Million - $3.45 Million
-12,600 Reduced 42.13%
17,310 $4.33 Million
Q4 2017

Feb 09, 2018
SELL
$216.94 - $271.3 $1.39 Million - $1.74 Million
-6,400 Reduced 17.63%
29,910 $7.14 Million
Q3 2017

Nov 14, 2017
BUY
$212.27 - $242.28 $594,356 - $678,384
2,800 Added 8.36%
36,310 $0
Q2 2017

Aug 17, 2017
BUY
N/A
33,510
33,510 $7.58 Million

Others Institutions Holding BIO

# of Institutions
466
Shares Held
18.7M
Call Options Held
23.2K
Put Options Held
37.4K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.95B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email